| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 08.05.
| AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results | | 11 | PR Newswire |
| REDWOOD CITY, Calif., May 8, 2012 /PRNewswire/ --AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization...
Mehr lesen zu:
AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results | |
| 17.04.
| AcelRx Pharmaceuticals Announces Hiring of Kim Gaumer as Vice President, Regulatory Affairs and Quality Assurance | | 25 | PR Newswire |
| REDWOOD CITY, Calif., April 17, 2012 /PRNewswire/ --AcelRx Pharmaceuticals, Inc. (ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...
Mehr lesen zu:
AcelRx Pharmaceuticals Announces Hiring of Kim Gaumer as Vice President, Regulatory Affairs and Quality Assurance | |
| 12.04.
| AcelRx Announces Initiation of Second Phase 3 Clinical Trial for ARX-01, the Sufentanil NanoTab® PCA System, for the Treatment of Acute Post-Operative Pain | | 17 | PR Newswire |
| REDWOOD CITY, Calif., April 12, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative...
Mehr lesen zu:
AcelRx Announces Initiation of Second Phase 3 Clinical Trial for ARX-01, the Sufentanil NanoTab® PCA System, for the Treatment of Acute Post-Operative Pain | |
| 11.04.
| AcelRx Pharmaceuticals Receives Two Notices of Allowance for Small-Volume Oral Transmucosal Dosage Forms | | 30 | PR Newswire |
| REDWOOD CITY, Calif., April 11, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies...
Mehr lesen zu:
AcelRx Pharmaceuticals Receives Two Notices of Allowance for Small-Volume Oral Transmucosal Dosage Forms | |
| 20.03.
| AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2011 Financial Results | | 13 | PR Newswire |
| REDWOOD CITY, Calif., March 20, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of...
Mehr lesen zu:
AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2011 Financial Results | |
| 07.03.
| AcelRx Announces Initiation of Phase 3 Clinical Program for ARX-01, the Sufentanil NanoTab® PCA System for the Treatment of Post-Operative Pain | | 79 | PR Newswire |
| REDWOOD CITY, Calif., March 6, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization...
Mehr lesen zu:
AcelRx Announces Initiation of Phase 3 Clinical Program for ARX-01, the Sufentanil NanoTab® PCA System for the Treatment of Post-Operative Pain | |
| 21.02.
| AcelRx Pharmaceuticals to Present at Two Near-Term Health Care Conferences | | 9 | PR Newswire |
| REDWOOD CITY, Calif., Feb. 21, 2012 /PRNewswire/ --AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of...
Mehr lesen zu:
AcelRx Pharmaceuticals to Present at Two Near-Term Health Care Conferences | |
| 31.01.
| AcelRx Announces its ARX-01 Phase 3 Program Expected to Start Late Q1 or Early Q2 2012 | | 24 | PR Newswire |
| REDWOOD CITY, Calif., Jan. 31, 2012 /PRNewswire/ --AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization...
Mehr lesen zu:
AcelRx Announces its ARX-01 Phase 3 Program Expected to Start Late Q1 or Early Q2 2012 | |
| 30.11.
| Stratos Product Development Provides Design Expertise on AcelRx Pharmaceuticals' Advanced Drug Delivery System for Acute Pain Management | | 28 | MarketWire |
| SEATTLE, WA -- (Marketwire) -- 11/30/11 -- Stratos Product Development LLC today announced its President, Sean MacLeod, and AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) Chief Executive Officer, Richard...
Mehr lesen zu:
Stratos Product Development Provides Design Expertise on AcelRx Pharmaceuticals' Advanced Drug Delivery System for Acute Pain Management | |
